Aggressive cutaneous infection with Mycobacterium marinum in two patients receiving anti-tumor necrosis factor-alfa agents

J Am Acad Dermatol. 2011 Nov;65(5):1060-2. doi: 10.1016/j.jaad.2008.12.041.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Arthritis, Psoriatic / drug therapy
  • Arthritis, Rheumatoid / drug therapy
  • Bacterial Typing Techniques
  • Clarithromycin / therapeutic use
  • Ethambutol / therapeutic use
  • Female
  • Fingers / microbiology
  • Fishes / microbiology
  • Hand Dermatoses / etiology
  • Hand Dermatoses / microbiology
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Infliximab
  • Methotrexate / therapeutic use
  • Middle Aged
  • Minocycline / therapeutic use
  • Mycobacterium Infections, Nontuberculous / diagnosis
  • Mycobacterium Infections, Nontuberculous / drug therapy
  • Mycobacterium Infections, Nontuberculous / etiology*
  • Mycobacterium marinum / isolation & purification*
  • Rifabutin / therapeutic use
  • Skin Diseases, Bacterial / diagnosis
  • Skin Diseases, Bacterial / drug therapy
  • Skin Diseases, Bacterial / etiology*
  • Skin Diseases, Bacterial / microbiology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Anti-Bacterial Agents
  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Rifabutin
  • Ethambutol
  • Infliximab
  • Minocycline
  • Clarithromycin
  • Methotrexate

Supplementary concepts

  • Infection with Mycobacterium marinum